RE: Presentation3 Oct 2023 12:24
They have been talking of investing in a new product for a long time now so i think it is premature to suggest that this small acquisition implies an issue or that they've given up with Nuvec.
Yes the acquisition appears cheap but from looking at the accounts of the seller it looks like they were v light in the cash department pre sale, hence maybe in a forced sale position. Older reports from 2018/19ish indicated that subsequent to previous lab work Nanogenics were then looking to list on the public market or progress via a new partner. Neither managed to get away so maybe to the next best option was progress the product via a partial sale to a listed vehicle (N4P).